Aeronautics
Space
Mobility
Digital
Healthtech
Agritech
Greentech
Other sectors
Healthtech
HealthTech is doing well in Toulouse! Public and private initiatives are multiplying in areas as diverse as cancer research, bioproduction, diabetes and obesity, with strong synergies particularly in the field of aeronautics.
The HealthTech sector, Toulouse’s economic driver, is supported by eight hospitals, nine clinics, 2,200 researchers and the Campus Santé du Futur (Health Campus of the Future), Oncopole.
Key areas of excellence include biotherapies, bioproduction, digital health, artificial intelligence, gerosciences and the fight against cancer (prevention, diagnosis, therapies). This ecosystem attracts talent, businesses and investors, strengthening the local economy while stimulating innovation.
Biotherapies/Bioproduction
Toulouse Métropole is a major hub for bioproduction and biotherapies in the Occitanie region, which has invested €36 million to support the sector since 2017. In 2024, Evotec inaugurated its J.POD® 2 plant (€150 million, 15,000 m²) on the Campus Santé du Futur to produce 2 tonnes of biological products per year, strengthening European health sovereignty. Toulouse Industrial Biotechnology for Health also plays a key role in bringing together research and industry to accelerate the production of biomedicines.
Digital Health
Toulouse is at the forefront of digital health, with patient monitoring applications, connected medical devices and artificial intelligence-based solutions. ANITI’s AI for Health programme, launched in 2023, brings together local players to develop innovative technologies. Certified French Tech Health Tech, Toulouse supports a dynamic ecosystem, with the Toulouse Digital Health third place funded to the tune of €1.5 million by the French government. ANITI and TSN are strengthening innovation for preventive and personalised medicine.
Pharmaceuticals
Toulouse is a leader in pharmaceutical research and development, notably with Pierre Fabre, a major player in cancer research and innovative therapeutic solutions. Evotec, a key CRO, supports pharmaceutical innovation by co-developing cutting-edge treatments. Finally, the entire Toulouse ecosystem supports industrial relocation, notably with Ipsophène, which produces 100% French paracetamol active ingredients.
Diagnostics
Toulouse also excels in the field of medical diagnostics, with major investments such as Siemens Healthineers, for the production of radiopharmaceuticals for positron emission tomography (PET) diagnostics. In 2025, IUCT-Oncopole took another step forward in medical innovation by installing a second 100% digital PET scanner and setting up an interventional radiology room within its operating theatre. These innovations are all aimed at improving the diagnosis and care of cancer patients.
Innovation
Campus “Santé du Futur”
On the banks of the Garonne River, the Campus “Santé du Futur” (The Future of Health) embodies Toulouse’s excellence in medical and biotechnological innovation. This exceptional site brings together researchers, companies and cutting-edge infrastructure in a sustainable and connected environment.
IUCT-Oncopole
The Toulouse University Cancer Institute – Oncopole is a cancer centre combining care, research and teaching. It brings together the Claudius Regaud Institute, Toulouse University Hospital and Paul Sabatier University. Its mission is to offer patients rapid access to innovative treatments.
Campus Santé du Futur
CRCT
The Toulouse Cancer Research Centre is a research laboratory dedicated to studying the mechanisms of cancer. It brings together researchers, clinicians and industrialists to develop new therapies and aims to accelerate the transfer of scientific discoveries to patients.
Campus Santé du Futur
Laboratoires Pierre Fabre
The Pierre Fabre Group is a major player in the fields of pharmaceuticals, oncology and dermo-cosmetics. The Campus site employs around 1,000 people and is dedicated to R&D in oncology. Another Pierre Fabre centre is located in the heart of Toulouse, at the Hôtel-Dieu, and is dedicated to skin research and the evaluation of dermo-cosmetic products.
Campus Santé du Futur
#chooseToulouse
Alia Santé
Toulouse Team – Invest accompanied and supported Alia Santé, a pioneering company specialising in artificial intelligence in the healthcare sector, in the process of establishing itself in Toulouse.
Sêmeia
Sêmeia designs cutting-edge digital solutions for monitoring patients with chronic or serious illnesses. Using real-time data analysis, the company improves risk prevention and the efficiency of medical teams. Sêmeia has benefited from Invest’s support to sustain its development and structure its growth.
Are you looking to develop your business in the healthcare sector?
Toulouse offers a unique ecosystem where innovation, expertise and synergies between research and industry combine to promote business success. Choose Toulouse and its healthcare sector and help shape the future of medicine.
Your contact
JENNIFER LARTIGUE
LIFE SCIENCES SALES ENGINEER
[email protected]@linkedin.com
Tel. +33 5 34 25 58 27 • Mob. +33 6 27 60 60 46
Success stories
